Mounjaro
-
How Eli Lilly CEO David Ricks Uses Weight-Loss Billions to Fund New Pipeline Bets
Backed by massive GLP-1 revenue, CEO David Ricks is directing Eli Lilly’s cash toward blood cancer, neuroscience, and immunology acquisitions.
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Bacteria Pair Cleared Tumours in Mice in 2025 Study; Not Yet Tested in People
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Could the Moderna-Merck Melanoma Vaccine Win FDA Approval Within Two Years? What We Know
-
FDA Rejects Capricor’s Deramiocel for Duchenne After Highlighting Data Reliability and Efficacy Gaps
-
How Eli Lilly CEO David Ricks Uses Weight-Loss Billions to Fund New Pipeline Bets
-
First FDA-Approved Drug for Type 3 Gaucher Neurological Symptoms Targets Ataxia and Cognition
-
GLP-1s Extend Beyond Weight Loss to Treat Heart Disease and Addiction
-
Sacituzumab Tirumotecan Boosts Survival in Advanced Gastroesophageal Cancer
-
Grant Cardone Sets $10 Million Net Worth as 2026 ‘Rich’ Threshold
-
How to Replace a $2,500 Monthly Pension With 401(k) Savings
-
How to Pay Down Credit Card Debt Before Holiday Spending Peaks
-
Small Business Sale Can Trigger Up to 37% Federal Tax, New Data Shows
-
Annuity Renewal Traps: How Automatic Rollovers Lock Retirees Into Lower Rates
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992

